Thereby, we demonstrated that vascular endothelial grow factor (VEGF), hypoxia-inducible factor 1-alpha (HIF), and fibronectin (FN1) expression were differentially over-expressed in low- risk MDS patients, including RCMD cases. The gene discussed is FN1; the disease is myelodysplastic syndrome with multilineage dysplasia.